Research funder · Australia
Therapeutic Innovation Australia
- Grants since 2016
- 310
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 146
- Funded works, all time
- 282
Grants
2026
Development of new anti-breast cancer antibodies for natural killer (NK) cell-based immunotherapy
2026
Improving mRNA vaccines for malaria with precision vaccinology
2026
IRAP Inhibitor Manufacturing
2026
Synthesis and Characterization of Transcription Factor Inhibitors for Therapeutic Interventions in Age-Related Conditions
2026
Development of an assay system to identify CNS-penetrant derivatives of pre-existing drugs for brain cancer
2026
Enabling translation of a therapeutic vaccine candidate against Porphyromonas gingivalis
2026
TRPC3 inhibitors for the treatment of cardiac disease
2026
Development of small molecule drugs in immuno-oncology
2026
BrainCAR19 Study - Treatment of relapsed Primary Brain Lymphoma with CD19 directed CAR-T cells
2026
Development of a New, Irresistible medicines for Malaria
2026
Improving adoptive cell therapy protocols through transcriptional rewiring of T cells
2026
In vivo and in vitro pharmacokinetic studies of novel therapeutics against blood cancers
2026
Development of novel agonists for schizophrenia
2026
Next-Generation Small Molecules for Alzheimer’s Therapy
2026
Assessing the pharmacokinetic profile of small molecules to promote cardiomyocyte specific proliferation
2026
Generation of Induced Pluripotent Stem Cell Master and Working Cell Banks for a Phase 1 Clinical Trial for the Treatment of Heart Failure
2026
Novel Receptor Agonists for difficult to treat chronic illness
2026
Retrieving short-term memories for tuberculosis treatment
2026
Small molecule drugs in immuno-oncology
2026
Developing a biomaterial for intra-operative delivery of mRNA therapeutics targeting the tumour microenvironment
2026
Preclinical toxicity studies for OmniCAR-enabled targeting ligands
2026
Lead-to-candidate optimisation of a small molecule oncology drug
2026
Optimisation of a therapeutic neurotrophin molecule to enable evaluation in a first in human clinical trial
2026
Harnessing mRNA Lipid Nanoparticles For Efficient Delivery Of Influenza Monoclonal Antibody Therapeutics
2026
Deciphering the mechanism of Rubinstein-Taybi Neurodevelopmental Syndrome and screening new therapeutic options
2026
Development of intra-articular SRPK1/CLK1 inhibitors for osteoarthritis pain
2026
Preparation of ADC and Radiotheranositics from our Nvel Covalently Binding T Cell Receptor Against Tumour-Associated Peptide–MHC Complex
2026
Modelling, synthesis and testing of potential agents against COVID-19 main protease
2026
Prevention of COVID-19-induced hyperinflammatory syndrome with the immunomodulatory protein AIP-2”
2026
Transformational Drug Discovery for TAOK1 Neurodevelopmental Disorder
2026
Assessing efficacy of analgesic nanoparticles in chemotherapy-induced neuropathic pain
2026
Identification of Inhibitors of a key oncogenic protein by Fragment Screening
2026
A GLP repeat dose oral toxicity study of Endo Axiom’s inverse vaccine for prevention of type 1 diabetes
2026
Synthesis of novel small molecule inhibitors of SLC7A11/XCT for mutant-p53 cancers
2026
Targeting novel RNA biology in cancer
2026
Identifying therapeutics for the treatment of Myelodysplastic Syndrome
2026
Improving mRNA vaccines with precision vaccinology
2026
Retrieving short-term memories for treatment of post-TB lung disease
2026
Development of a novel METTL1-specific PROTAC protein degrader
2026